Alendronate has been shown to increase bone mineral density (BMD) and decrease fracture risk in postmenopausal women with osteoporosis, but the need for long-term treatment is unclear, especially ...

Alendronate sodium is a bisphosphonate used to treat Paget disease of bone (PDB). The approved dosage of 40 mg/day for 6 months is generally well tolerated, but esophageal irritation can occur if ...

Alendronate (as sodium) 70mg/75mL; raspberry flavor; contain parabens. Swallow whole. Take in the AM with plain (not mineral) water only, at least 30 mins before the first food, drink, or ...

Alendronate (Fosamax) reduces fracture rates among women with osteoporosis, usually defined as bone mineral density T-scores lower than -2.5. However, the benefit of alendronate in women with ...

Alendronate (as sodium), cholecalciferol (Vit ... For patients at low-risk for fracture, consider drug discontinuation after 3–5yrs. Swallow whole. Take in the AM with plain (not mineral ...

Compared with alendronate, teriparatide was associated with significantly greater pain reduction and better quality of life among postmenopausal women with osteoporosis. Teriparatide has a ...